相关实验视频
Updated: Jan 18, 2026

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
81.8K
精密结核病治疗的工程里芬素封装的可吸入微粒:体内分布和治疗评估
Ruchi Tiwari1, Patibandla Jahnavi2, Dhakshnamoorthy Vellingiri3
1PSIT-Pranveer Singh Institute of Technology (Pharmacy), Kanpur-Agra-Delhi National, Kanpur, Uttar Pradesh, India.
Journal of drug targeting
|September 8, 2025
概括
这项研究开发了含有里芬素的PLGA微粒,用于向结核病吸入治疗. 这种新型配方证明了药物递送的改善,小鼠的细菌负载降低,以及24个月的保质期.
科学领域:
- 制药科学 制药科学
- 生物技术是生物技术.
- 医学微生物学 医学微生物学
背景情况:
- 结核病 (TB) 仍然是一个重大的全球卫生挑战,需要先进的药物输送系统.
- 目前的治疗方法面临着有效性和患者遵从性的挑战.
- 部位特异性肺药物输送为结核病治疗提供了一个有前途的替代方案.
研究的目的:
- 制定和优化用于吸入治疗的里芬素封装PLGA微粒.
- 评估微粒子配方的体内疗效和药物动力学概况.
- 通过计算建模来确定最佳的气溶沉积参数.
主要方法:
- 使用喷雾干燥生产微粒,并通过实验设计 (DOE) 进行优化.
- 评估了空气动力学特性 (MMAD,FPF).
- 在小鼠和大鼠的体内研究评估了肺部停留时间和疗效.
- 计算流体动力学 (CFD) 和人工智能建模预测了气溶沉积.
主要成果:
- 优化的微粒子实现了所需的空气动力学特性 (MMAD 2.5微米,FPF 62%).
- 里芬素封装显著延长了肺部停留时间 (2.4倍高于口服).
- 在膜区域的最大气溶沉积量 (52.8%) 预计为30L/分钟.
- 结核病感染的小鼠显示肺部细菌负荷降低 (3.2 log CFU) 和调节的炎症标志物 (TNF-α降低,IL-10增加).
- 加速稳定性测试表明,配方的保质期为24个月.
结论:
- 含有利芬素的PLGA微粒是针对性肺结核治疗的可行平台.
- 该配方增强了药物的停留时间和有效性,减少了细菌负载和炎症.
- 计算建模有助于优化吸入参数,以获得最大的气泡膜沉积.
- 开发出的微粒具有有利的稳定性,表明临床潜力.
相关概念视频
Pulmonary Tuberculosis V
543
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
543
Pulmonary Tuberculosis IV
480
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
480
Pulmonary Tuberculosis I
846
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
846
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis III
946
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
946

